Loading...
Loading...
Life Technologies Corporation
LIFE today announced that the company has entered into a
Master Development Agreement with Bristol-Myers Squibb Company
BMY for
current and future companion diagnostics projects. The current agreement
constitutes the second collaboration between the two companies and represents
another step in Life Technologies' strategy to develop its diagnostic business
through internal development, partnerships and select acquisitions.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in